ROHIT J PARMAR

Allopathic & Osteopathic Physicians|Nuclear Medicine|Nuclear Cardiology DALLAS, TX NPI 1114985405

General Payments — all program years on this page

$3,167.77

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 193
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $584.20 across 40 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $584.2040

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $303.0721
2019 $276.0216
2020 $107.807
2021 $439.0321
2022 $629.9345
2023 $827.7243
2024 $584.2040

Records — PY2024 (40)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087270291 Novartis Pharmaceuticals Corporation $13.79 01/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270293 Novartis Pharmaceuticals Corporation $6.98 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270303 Novartis Pharmaceuticals Corporation $7.49 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270305 Novartis Pharmaceuticals Corporation $8.56 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270313 Novartis Pharmaceuticals Corporation $17.31 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270327 Novartis Pharmaceuticals Corporation $15.97 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270331 Novartis Pharmaceuticals Corporation $6.83 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270347 Novartis Pharmaceuticals Corporation $11.48 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270353 Novartis Pharmaceuticals Corporation $11.04 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270367 Novartis Pharmaceuticals Corporation $21.80 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270377 Novartis Pharmaceuticals Corporation $13.23 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270383 Novartis Pharmaceuticals Corporation $15.27 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270385 Novartis Pharmaceuticals Corporation $14.84 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270387 Novartis Pharmaceuticals Corporation $9.25 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087270389 Novartis Pharmaceuticals Corporation $11.61 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096730644 Novo Nordisk Inc $17.11 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097481364 Novo Nordisk Inc $17.04 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101231479 E.R. Squibb & Sons, L.L.C. $28.87 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101231491 E.R. Squibb & Sons, L.L.C. $17.34 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105806384 AstraZeneca Pharmaceuticals LP $15.12 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995244 Amgen Inc. $11.87 01/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995248 Amgen Inc. $16.02 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995253 Amgen Inc. $9.37 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995259 Amgen Inc. $17.74 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995265 Amgen Inc. $10.42 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995273 Amgen Inc. $15.89 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995279 Amgen Inc. $15.12 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995287 Amgen Inc. $16.76 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995293 Amgen Inc. $14.29 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995299 Amgen Inc. $17.79 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115995305 Amgen Inc. $14.87 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131053644 PFIZER INC. $19.53 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131397821 PFIZER INC. $16.77 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146872730 Philips North America LLC $15.68 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146872732 Philips North America LLC $15.62 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146872736 Philips North America LLC $14.25 06/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146872738 Philips North America LLC $14.34 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146872740 Philips North America LLC $15.81 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146872742 Philips North America LLC $14.03 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154867019 Kiniksa Pharmaceuticals International, plc $17.10 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.